MedTrace Logo

Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus

NCT00208936 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-09-09

No results posted yet for this study

Summary

This study is designed pre-operative for patients with resectable, local-regional carcinoma of the esophagus.

Conditions

  • Esophageal Diseases

Interventions

DRUG

Taxol, Cisplatin, 5-Fluorouracil, G-CSF

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Michael Fanucchi, MD · Emory University Winship Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-01-31
Primary Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00208936 on ClinicalTrials.gov